CompuGroup Medical Societas Europaea develops and sells software and information technology services for the healthcare sector worldwide.
Average dividend payer with mediocre balance sheet.
Share Price & News
How has CompuGroup Medical Societas Europaea's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: COP's share price has been volatile over the past 3 months.
7 Day Return
DE Healthcare Services
1 Year Return
DE Healthcare Services
Return vs Industry: COP underperformed the German Healthcare Services industry which returned 10.7% over the past year.
Return vs Market: COP exceeded the German Market which returned 5.6% over the past year.
Price Volatility Vs. Market
How volatile is CompuGroup Medical Societas Europaea's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StIs CompuGroup Medical Societas Europaea (ETR:COP) Creating Value For Shareholders?
3 weeks ago | Simply Wall StCould CompuGroup Medical Societas Europaea's (ETR:COP) Investor Composition Influence The Stock Price?
1 month ago | Simply Wall StHow Much Did CompuGroup Medical Societas Europaea's (ETR:COP) CEO Pocket Last Year?
Is CompuGroup Medical Societas Europaea undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: COP (€71.1) is trading above our estimate of fair value (€44.12)
Significantly Below Fair Value: COP is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: COP is poor value based on its PE Ratio (59.1x) compared to the Healthcare Services industry average (14.6x).
PE vs Market: COP is poor value based on its PE Ratio (59.1x) compared to the German market (20.3x).
Price to Earnings Growth Ratio
PEG Ratio: COP is poor value based on its PEG Ratio (4.7x)
Price to Book Ratio
PB vs Industry: COP is overvalued based on its PB Ratio (12.8x) compared to the DE Healthcare Services industry average (3.6x).
How is CompuGroup Medical Societas Europaea forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: COP's forecast earnings growth (12.6% per year) is above the savings rate (0.2%).
Earnings vs Market: COP's earnings (12.6% per year) are forecast to grow slower than the German market (23% per year).
High Growth Earnings: COP's earnings are forecast to grow, but not significantly.
Revenue vs Market: COP's revenue (5.7% per year) is forecast to grow slower than the German market (5.8% per year).
High Growth Revenue: COP's revenue (5.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: COP's Return on Equity is forecast to be high in 3 years time (38.9%)
How has CompuGroup Medical Societas Europaea performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: COP has high quality earnings.
Growing Profit Margin: COP's current net profit margins (7.4%) are lower than last year (12.9%).
Past Earnings Growth Analysis
Earnings Trend: COP's earnings have grown by 19.2% per year over the past 5 years.
Accelerating Growth: COP's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: COP had negative earnings growth (-39.9%) over the past year, making it difficult to compare to the Healthcare Services industry average (18.3%).
Return on Equity
High ROE: Whilst COP's Return on Equity (21.65%) is high, this metric is skewed due to their high level of debt.
How is CompuGroup Medical Societas Europaea's financial position?
Financial Position Analysis
Short Term Liabilities: COP's short term assets (€273.3M) do not cover its short term liabilities (€276.4M).
Long Term Liabilities: COP's short term assets (€273.3M) do not cover its long term liabilities (€562.6M).
Debt to Equity History and Analysis
Debt Level: COP's debt to equity ratio (163%) is considered high.
Reducing Debt: COP's debt to equity ratio has reduced from 180.4% to 163% over the past 5 years.
Debt Coverage: COP's debt is well covered by operating cash flow (24.4%).
Interest Coverage: COP's interest payments on its debt are well covered by EBIT (18.7x coverage).
What is CompuGroup Medical Societas Europaea's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: COP's dividend (0.7%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1.26%).
High Dividend: COP's dividend (0.7%) is low compared to the top 25% of dividend payers in the German market (3.74%).
Stability and Growth of Payments
Stable Dividend: COP's dividends per share have been stable in the past 10 years.
Growing Dividend: COP's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (41.6%), COP's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: COP's dividends in 3 years are forecast to be well covered by earnings (21.3% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Frank Gotthardt (69yo)
Mr. Frank Gotthardt has been the Chairman of Management Board and Chief Executive Officer of CompuGroup Medical Societas Europaea (formerly, CompuGroup Holding AG) since July 1, 2008. He has been Chairman ...
CEO Compensation Analysis
Compensation vs Market: Frank's total compensation ($USD4.55M) is above average for companies of similar size in the German market ($USD2.43M).
Compensation vs Earnings: Frank's compensation has been consistent with company performance over the past year.
|Chairman of Management Board & CEO||11.92yrs||€4.02m||37% €1.3b|
|CFO & Member of Management Board||0.83yr||€666.39k||0.0045% €156.3k|
|Member of Executive Board||1.58yrs||€736.88k||0.0031% €106.7k|
|Chief Process Officer & Member of Management Board||5.17yrs||€589.15k||0.0027% €91.2k|
|Member of Executive Board||1.58yrs||€761.19k||no data|
|Director of CHS Consumer & Health Management Services and Member of the Management Board||0.58yr||€473.51k||no data|
|Head of Investor Relations||no data||no data||no data|
|Senior Vice President of Northern America & Canada||3.42yrs||no data||no data|
|Chief Communication Officer of Political & Public Affairs||no data||no data||no data|
|Senior Vice President of Asian & African Region||5.42yrs||no data||no data|
Experienced Management: COP's management team is considered experienced (2.5 years average tenure).
|Independent Chairman of Supervisory Board||6.08yrs||€90.00k||0.29% €10.0m|
|Member of Supervisory Board||0.083yr||no data||no data|
|Independent Member of Supervisory Board||2.33yrs||€60.00k||no data|
|Deputy Chairman of Supervisory Board||no data||€60.00k||7.38% €253.9m|
|Member of Medical Advisory Board||no data||no data||no data|
|Independent Member of Supervisory Board||3.08yrs||€60.00k||no data|
|Employee Representative Supervisory Board Member||4.33yrs||€60.00k||no data|
|Employee Representative Supervisory Board Member||4.33yrs||€60.00k||no data|
Experienced Board: COP's board of directors are considered experienced (3.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
CompuGroup Medical Societas Europaea's company bio, employee growth, exchange listings and data sources
- Name: CompuGroup Medical Societas Europaea
- Ticker: COP
- Exchange: XTRA
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: €3.442b
- Shares outstanding: 48.41m
- Website: https://www.cgm.com
Number of Employees
- CompuGroup Medical Societas Europaea
- Maria Trost 21
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|COP||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Jul 1996|
|0MSD||LSE (London Stock Exchange)||Yes||Common Shares||GB||EUR||Jul 1996|
|CMPV.F||OTCPK (Pink Sheets LLC)||Yes||Common Shares||US||USD||Jul 1996|
|COP||XTRA (XETRA Trading Platform)||Yes||Common Shares||DE||EUR||Jul 1996|
|COPD||BATS-CHIXE (BATS 'Chi-X Europe')||Yes||Common Shares||GB||EUR||Jul 1996|
|COP||WBAG (Wiener Boerse AG)||Yes||Common Shares||AT||EUR||Jul 1996|
|COMPG||SWX (SIX Swiss Exchange)||Yes||Common Shares||CH||CHF||Jul 1996|
|COP||ETLX (Eurotlx)||Yes||Common Shares||IT||EUR||Jul 1996|
|COP1 N||BMV (Bolsa Mexicana de Valores)||Yes||Common Shares||MX||MXN||Jul 1996|
|CMPU.Y||OTCPK (Pink Sheets LLC)||ADR||US||USD||Mar 2012|
CompuGroup Medical Societas Europaea develops and sells software and information technology services for the healthcare sector worldwide. It operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS). The AIS segment provides practice management software and electronic medical records for doctors in private practice, medical care centers, and doctor’s networks, as well as offers supplementary Internet and intranet solutions. The PCS segment provides integrated clinical, administrative, and billing-related software applications for pharmacies, as well as in-store and online merchandising programs supported by paper-based and electronic communication and advertising solutions. The HIS segment provides clinical and administrative solutions for the inpatient sector. This segment serves acute care hospitals; rehabilitation centers; and social services, including multi-location hospital networks and regional care organizations. The CHS segment provides communication and data solutions that allow pharmaceutical companies to provide information to healthcare providers through software interfaces. This segment offers clinical decision support systems, and medications and therapy databases for healthcare providers; and personal health records, consumer portals, and mobile applications solutions for healthcare IT companies, as well as collects and transfers anonymous clinical data for market studies, clinical trials, etc. It serves pharmaceutical companies, health insurance companies, and other healthcare IT companies and consumers. The company was formerly known as CompuGroup Medical Aktiengesellschaft and changed its name to CompuGroup Medical Societas Europaea in February 2016. CompuGroup Medical Societas Europaea is headquartered in Koblenz, Germany.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/06/05 10:19|
|End of Day Share Price||2020/06/04 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.